ECM
MBIO icon

ExodusPoint Capital Management’s Mustang Bio MBIO Stock Holding History

ExodusPoint Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-70
Closed -$87K – 2475
2021
Q4 		$87K Buy
70
+2
+3% +$3.23K ﹤0.01% 1972
2021
Q3 		$138K Buy
68
+20
+42% +$43K ﹤0.01% 1855
2021
Q2 		$120K Buy
48
+4
+9% +$9.8K ﹤0.01% 2111
2021
Q1 		$109K Buy
+44
New +$131K ﹤0.01% 1971
2020
Q4 		– Sell
-15
Closed -$36K – 2205
2020
Q3 		$36K Buy
+15
New +$37K ﹤0.01% 1648

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ExodusPoint Capital Management's MBIO Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of Mustang Bio (MBIO) in Q1 2022, closing a stake of 70 shares — an estimated $87K sold.

ExodusPoint Capital Management first reported a position in MBIO in Q3 2020 and held it in 5 quarters. The position peaked at $138K in Q3 2021. 81 funds tracked by Wall St. Rank hold MBIO as of Q1 2022.

  • ExodusPoint Capital Management reported no remaining Mustang Bio position as of Q1 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 70 Mustang Bio shares in Q1 2022, an estimated $87K.
  • ExodusPoint Capital Management first reported a position in Mustang Bio in Q3 2020 and held it in 5 quarters.
  • ExodusPoint Capital Management's Mustang Bio position peaked at $138K in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.